India-EFTA Trade and Economic Partnership Agreement (TEPA)
Context:
The Trade and Economic Partnership Agreement (TEPA) between India and the European Free Trade Association (EFTA) countries, signed on March 10, 2024, came into force on October 1, 2025.
This is India's first Free Trade Agreement (FTA) with a bloc of four developed European nations.
What is EFTA?
The European Free Trade Association (EFTA) is an intergovernmental organization established in 1960 to promote free trade and economic integration among its members
Member Countries:
Iceland
Liechtenstein
Norway
Switzerland
It is one of the three major economic blocs in Europe.
Other two are the European Union (EU) and the United Kingdom (UK)
Key Features of TEPA:
Investment and Job Creation:
For the first time in any Indian FTA, TEPA includes a legally binding commitment from EFTA countries to invest USD 100 billion in India over the next 15 years.
The agreement also aims to create 1 million direct jobs in India during the same period.
Market Access and Tariff Concessions:
EFTA's Offer:
Provides tariff concessions on 92.2% of its tariff lines, which covers 99.6% of India's exports.
This includes all non-agricultural goods and processed agricultural products.
India's Offer:
India has extended access on 82.7% of its tariff lines, accounting for 95.3% of EFTA's exports.
Safeguards for India:
Key sensitive sectors like dairy, soya, coal, and select agricultural products have been kept on the exclusion list to protect domestic industries.
Services Sector:
The pact significantly boosts trade in services.
India has made commitments in 105 sub-sectors, while EFTA has offered access in up to 128 sub-sectors, including key areas like IT, business services, and education.
A key provision is the inclusion of Mutual Recognition Agreements (MRAs) for professionals in fields such as nursing, chartered accountancy, and architecture, which will ease professional mobility.
Intellectual Property Rights (IPR):
The agreement reaffirms commitments under the TRIPS agreement and ensures a high level of protection.
It preserves India's policy space and flexibility on public health issues.
This includes safeguards against patent evergreening to protect affordable access to medicines.